Culturally Adapted Contingency Management
Cultural Adaptation of Contingency Management for Black Adults With Stimulant Use Disorder
2 other identifiers
interventional
70
1 country
1
Brief Summary
The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2030
March 2, 2026
February 1, 2026
4 years
February 24, 2026
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Percent negative urine samples
Participants will provide urine samples twice weekly. Percent of negative urines provided will be calculated.
Week 12
Mean longest duration of abstinence
The longest duration of abstinence in days will be measured.
Week 12
Secondary Outcomes (4)
Mean treatment retention
Baseline and Week 12.
Acceptability of Intervention Measure (AIM)
Week 12
Feasibility of Intervention Measure (FIM)
Week 12
Client Satisfaction Questionnaire (CSQ-8)
Week 12
Study Arms (3)
Culturally Adapted CM
EXPERIMENTALParticipants in this arm will receive the culturally adapted CM over a 12- week treatment period
Basic CM
EXPERIMENTALParticipants in this arm will receive the basic CM over a 12- week treatment period
Standard Care Condition
NO INTERVENTIONIntensive Outpatient clinic (IOP) at substance use treatment and addiction (SATU) clinic twice every week, one day for group and the other for individual counseling
Interventions
Same protocol as basic CM with adaptations incorporated. The adaption will involve the ADAPT-ITT framework and PEN-3 cultural model.
An escalating schedule of reinforcement for submitting stimulant-negative urine at each clinic visit over the course of the 12 weeks
Eligibility Criteria
You may qualify if:
- participants must self-identify as Black/African American
- DSM-5 diagnosis of stimulant use disorder in the past month (30 days)
You may not qualify if:
- individuals who are intoxicated or otherwise unable to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Drug Abuse (NIDA)collaborator
- Yale Universitylead
Study Sites (1)
Connecticut Mental Health Center (CMHC)
New Haven, Connecticut, 06519, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Oluwole Jegede, MD, PhD
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 2, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
March 1, 2030
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share